Good news for BRAF pos Melanoma patients- the FDA has just approved the GSK BRAF-MEK combo which prolongates time to resistance and that with fewer side effects!
Now fingers crossed that the EMA follows closely, so that also European patients can get access to what has been promising ASCO news for the last 3 times.
Thanks for posting. Given where I started (heavy tumor burden), I literally owe my life to this combination and am forever grateful to the scientists, clinicians and patients who helped make it available.
This combo worked for me for 6 months. I acheived a 66% tumor reduction, but then went resistant to it. I did have to undergo a reduction in dosage due to side effects, mainly kidney